Skip to content

Ensuring Communication in Hospice by Oncology Study (ECHO)

Ensuring Communication in Hospice by Oncology Study (ECHO)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02069769
Enrollment
30
Registered
2014-02-24
Start date
2014-01-31
Completion date
2017-01-31
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervical Cancer, Head and Neck Cancer, Melanoma, Ovarian Cancer, Sarcoma, Uterine Cancer

Keywords

Hospice Care, Head and Neck cancer, Gynecological Oncology, Sarcoma, Melanoma

Brief summary

The goal of this study is to determine if scheduled communication with the oncology team through phone calls is helpful to caregivers with the transition to hospice care.

Detailed description

There are four parts of the study. First, the participant will receive phone calls twice a week from the oncology team to check in with how the transition to hospice is going. Second, the participant may choose to have an appointment with the Massachusetts General Hospital oncology team to discuss any questions or concerns regarding cancer care or the transition to hospice. Third, each week of hospice care, the participant will be asked to complete a set of questionnaires at a time that is convenient for them either by phone or by email. These questions will ask the participant about their recent thoughts and feelings about their experience with hospice and as a caregiver. The questions will take less than 15 minutes to answer. Fourth, after hospice care has ended, the participant will be called by the oncology team to again check in and about a month later, the participant will also be contacted by phone to complete a set of questionnaires, again asking about their thoughts and feelings about your experience with hospice and as a caregiver. For all of the questionnaires, the participant may skip any questions that the participant prefers not to answer. The responses will remain confidential and will be available only to study staff members who are trained in confidentiality and research ethics. Additionally, during the research study, the investigators will obtain information from the participant's loved one's Massachusetts General Hospital electronic medical record that is relevant to the participation in the study for up to 6 months. If he/she has visited another hospital during this time, the investigator will also ask the participant for their permission to obtain the medical records from this visit. The participant will not receive any compensation for this study.

Interventions

BEHAVIORALcommunication with oncology team

Oncology team will contact patients and families via telephone at specific intervals

Sponsors

Massachusetts General Hospital
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Adult Patient Criteria --\>18years of age) with a diagnosis of an incurable malignancy of the head and neck, gynecological oncology, sarcoma, or melanoma * Receiving oncology care at the MGH Cancer Center * Referral to home hospice services in previous five business days. * Family Caregiver Eligibility Criteria: * Designated adult family/informal caregiver for an eligible patient who will provide the primary home care for the patient receiving hospice services * Ability to read and respond to questions in English or with the assistance of a translator * Access to telephone and/or computer to communicate with the oncology team and complete questionnaires * Willingness to complete weekly questionnaires via telephone or email.

Exclusion criteria

* Patient

Design outcomes

Primary

MeasureTime frameDescription
Evaluate the feasibility of implementing the Ensuring Communication in Hospice by Oncology Study (ECHO) intervention by patients' family caregivers and their oncology providers.2 YearsECHO will be considered feasible if greater than 70% of participants have \> 50% of the scheduled phone contact with the oncology team during hospice care, which will be documented in the patient's medical record. Feasibility will also be demonstrated if greater than 70% of the family caregivers completing the questionnaires do so greater than 50% of the time they were scheduled. Finally, feasibility will also be demonstrated if caregivers are able to be contacted and decide upon participation within 5 days of patient hospice enrollment.

Secondary

MeasureTime frame
Prospectively explore the satisfaction with the overall experience of family caregivers through questionnaires when receiving the ECHO intervention.2 Years
Prospectively explore rates of health service utilization in the patients receiving the ECHO intervention in terms of (1) hospice disenrollment; (2) hospitalization; and (3) emergency department visits2 Years
Prospectively explore the levels of stress of family caregivers through questionnaires when receiving the ECHO intervention.2 years
Prospectively explore decision making regret of family caregivers through questionnaires when receiving the ECHO intervention.2 years

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 4, 2026